No. of individuals who died/ No. of individuals at risk (%) | ||||
---|---|---|---|---|
Point Score | Development Cohort | Validation Cohort | Lee et al. (2006) | Kobayashi et al. (2017) |
0 | 3/741 (< 1) | 5/720 (1) | 0/372 (< 1) | 2/393 (1) |
1 | 6/815 (1) | 9/786 (1) | 5/379 (1) | 4/439 (1) |
2 | 7/427 (2) | 10/445 (2) | 10/785 (1) | 9/523 (2) |
3 | 11/554 (2) | 21/548 (4) | 14/610 (2) | 18/676 (3) |
4 | 13/378 (3) | 13/337 (4) | 26/542 (5) | 8/306 (3) |
5 | 30/429 (7) | 31/466 (7) | 17/436 (4) | 16/418 (4) |
6 | 23/222 (10) | 28/211 (13) | 21/307 (7) | 8/213 (4) |
7 | 33/219 (15) | 22/184 (12) | 38/241 (16) | 26/373 (7) |
8 | 25/131 (19) | 29/147 (20) | 18/122 (15) | 12/170 (7) |
9 | 18/75 (24) | 19/78 (24) | 17/91 (19) | 35/209 (17) |
10 | 20/64 (31) | 24/62 (39) | 20/58 (34) | 13/92 (14) |
11 | 10/24 (42) | 9/29 (31) | 10/32 (31) | 17/64 (27) |
12 | 6/11 (56) | 5/9 (56) | 18/40 (45) | 11/51 (22) |
13 | 8/14 (57) | 2/15 (13) | 6/15 (40) | 10/32 (31) |
> 14 | 3/4 (75) | 3/7 (43) | 8/23 (35) | 8/94 (9) |
ROC Area | 0.816 | 0.774 | 0.784 | 0.779 |